Nike Stock at $100: Time to Buy?
Nike hasn't thrilled Wall Street with its latest earnings updates.
Stay updated with breaking news from Projected Sales. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nike hasn't thrilled Wall Street with its latest earnings updates.
(Reuters) -Biogen on Tuesday forecast flat 2024 product revenue as top-selling drugs face tough competition and sales of newer treatments take off slowly, but said there are signs its new Alzheimer's drug is gaining traction. Shares of the U.S. biotech fell 7% as it missed Wall Street expectations for quarterly revenue and projected sales for this year that several analysts found underwhelming. Sales of pricey spinal muscular atrophy drug Spinraza, which is dealing with fresh competition, also missed estimates.
Initiating a Bubble packing papers venture requires an investment of over Rs 15.06 lakh, for which you can also avail loan under PM Mudra Yojna.
This quality company has broad-based investment appeal for many types of investors. Read what you need to know about Eaton stock here.